133 related articles for article (PubMed ID: 6343032)
1. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects.
Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Matsuda A
Diabetes Care; 1983; 6 Suppl 1():17-22. PubMed ID: 6343032
[TBL] [Abstract][Full Text] [Related]
2. The clinical pharmacology of human insulin (Novo) in normal subjects.
Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG
Diabetes Care; 1983; 6 Suppl 1():13-6. PubMed ID: 6133710
[TBL] [Abstract][Full Text] [Related]
3. A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects.
Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; Home PD
Diabete Metab; 1982 Jun; 8(2):155-8. PubMed ID: 7049781
[TBL] [Abstract][Full Text] [Related]
4. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin.
Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W
Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554
[TBL] [Abstract][Full Text] [Related]
5. Human proinsulin: bioactivity and pharmaco-kinetics after intravenous and subcutaneous administration.
Schatz H; Ammermann S
Horm Metab Res Suppl; 1988; 18():1-5. PubMed ID: 3056805
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man.
Owens DR; Jones MK; Birtwell AJ; Burge CT; Jones IR; Heyburn PJ; Hayes TM; Heding LG
Horm Metab Res; 1984 Dec; 16 Suppl 1():195-9. PubMed ID: 6152435
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man.
Home PD; Shepherd GA; Noy G; Massi-Benedetti M; Hanning I; Burrin JM; Alberti KG
Diabetes Care; 1983; 6 Suppl 1():23-8. PubMed ID: 6343033
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection.
Schatz H; Ammermann S; Laube H; Federlin K
Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs.
Plum A; Agerso H; Andersen L
Drug Metab Dispos; 2000 Feb; 28(2):155-60. PubMed ID: 10640512
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of five pre-mixed combinations of 'short-' and 'intermediate-acting' (NPH) insulins in healthy subjects following subcutaneous administration.
Owens DR; Jones AL; Dolben J; Dean JD; Petocz P; Coates PA; Luzio SD
Diabetes Res; 1993; 22(2):77-86. PubMed ID: 8205740
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of soluble porcine and human insulin (Novo) using the artificial pancreas.
Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J
Diabetes Care; 1983; 6 Suppl 1():40-2. PubMed ID: 6343037
[TBL] [Abstract][Full Text] [Related]
15. Semisynthetic human insulin: biological and pharmacokinetic effects in normal subjects.
Brogard JM; Paris-Bockel D; Blickle JF; Cohen B; Pinget M; Stahl A
Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):238-43. PubMed ID: 3298081
[TBL] [Abstract][Full Text] [Related]
16. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers.
Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of human insulin of recombinant DNA origin in healthy volunteers.
Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Tarui S
Diabetes Care; 1982; 5 Suppl 2():35-8. PubMed ID: 6765537
[TBL] [Abstract][Full Text] [Related]
18. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of porcine and human regular insulins using an artificial pancreas].
Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J; Monnier L
Nouv Presse Med; 1982 Nov; 11(45):3331-3. PubMed ID: 6760120
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins.
George E; Bedford C; Peacey SR; Hardisty CA; Heller SR
Diabet Med; 1997 Jun; 14(6):442-8. PubMed ID: 9212308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
